Is Cytodyn in a quiet period? It seems that mgmt went out of their way to keep investors informed before and during ESMO. After ESMO it’s been crickets.

Dr. Jay has an uncanny feel for communicating with shareholders. He isn’t tone deaf. The new comms company has also been impressive so far.

Investors hate vacuums, especially when PR’s are required to move the needle. This silence feels self-imposed. OTOH, I’m merely speculating. That’s what we do when news is anticipated, but not provided.